Veru's muscle preserving drug meets main goal in mid-stage study

Veru

27/01/2025 11:38

Jan 27 (Reuters) - Veru  VERU.O  said on Monday its
experimental drug, in combination with Novo Nordisk's  NOVOb.CO 
weight-loss treatment Wegovy, helped preserve muscle in older
patients with obesity, meeting the main goal of a mid-stage
study. 

 (Reporting by Bhanvi Satija in Bengaluru; Editing by Arun
Koyyur)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))